1-7 of 7
Noriyuki Sato
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Olfactory Receptor Family 7 Subfamily C Member 1 Is a Novel Marker of Colon Cancer–Initiating Cells and Is a Potent Target of Immunotherapy

Rena Morita, Yoshihiko Hirohashi, Toshihiko Torigoe, Satoko Ito-Inoda, Akari Takahashi, Tasuku Mariya, Hiroko Asanuma, Yasuaki Tamura, Tomohide Tsukahara, Takayuki Kanaseki, Terufumi Kubo, Goro Kutomi, Toru Mizuguchi, Takeshi Terui, Kunihiko Ishitani, Satoshi Hashino, Toru Kondo, Nozomi Minagawa, Norihiko Takahashi, Akinobu Taketomi, Satoru Todo, Masahiro Asaka, Noriyuki Sato
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (13): 3298–3309.
https://doi.org/10.1158/1078-0432.CCR-15-1709
Published: 30 June 2016
View article titled, Olfactory Receptor Family 7 Subfamily C Member 1 Is a Novel Marker of Colon Cancer–Initiating Cells and Is a Potent Target of Immunotherapy
Open the PDF for Olfactory Receptor Family 7 Subfamily C Member 1 Is a Novel Marker of Colon Cancer–Initiating Cells and Is a Potent Target of Immunotherapy in another window
Includes: Supplementary data
Journal Articles

Identification of an Immunogenic CTL Epitope of HIFPH3 for Immunotherapy of Renal Cell Carcinoma

Eiji Sato, Toshihiko Torigoe, Yoshihiko Hirohashi, Hiroshi Kitamura, Toshiaki Tanaka, Ichiya Honma, Hiroko Asanuma, Kenji Harada, Hideo Takasu, Naoya Masumori, Naoki Ito, Tadashi Hasegawa, Taiji Tsukamoto, Noriyuki Sato
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (21): 6916–6923.
https://doi.org/10.1158/1078-0432.CCR-08-0466
Published: 03 November 2008
View article titled, Identification of an Immunogenic CTL Epitope of HIFPH3 for Immunotherapy of Renal Cell Carcinoma
Open the PDF for Identification of an Immunogenic CTL Epitope of HIFPH3 for Immunotherapy of Renal Cell Carcinoma in another window
Journal Articles

Effect of Human Leukocyte Antigen Class I Expression of Tumor Cells on Outcome of Intravesical Instillation of Bacillus Calmette-Guerin Immunotherapy for Bladder Cancer

Hiroshi Kitamura, Toshihiko Torigoe, Ichiya Honma, Eiji Sato, Hiroko Asanuma, Yoshihiko Hirohashi, Noriyuki Sato, Taiji Tsukamoto
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (15): 4641–4644.
https://doi.org/10.1158/1078-0432.CCR-06-0595
Published: 09 August 2006
View article titled, Effect of Human Leukocyte Antigen Class I Expression of Tumor Cells on Outcome of Intravesical Instillation of Bacillus Calmette-Guerin Immunotherapy for Bladder Cancer
Open the PDF for Effect of Human Leukocyte Antigen Class I Expression of Tumor Cells on Outcome of Intravesical Instillation of Bacillus Calmette-Guerin Immunotherapy for Bladder Cancer in another window
Journal Articles

Identification of HLA-A2- or HLA-A24-Restricted CTL Epitopes Possibly Useful for Glypican-3-Specific Immunotherapy of Hepatocellular Carcinoma

Hiroyuki Komori, Tetsuya Nakatsura, Satoru Senju, Yoshihiro Yoshitake, Yutaka Motomura, Yoshiaki Ikuta, Daiki Fukuma, Kazunori Yokomine, Michiko Harao, Toru Beppu, Masanori Matsui, Toshihiko Torigoe, Noriyuki Sato, Hideo Baba, Yasuharu Nishimura
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (9): 2689–2697.
https://doi.org/10.1158/1078-0432.CCR-05-2267
Published: 04 May 2006
View article titled, Identification of HLA-A2- or HLA-A24-Restricted CTL Epitopes Possibly Useful for Glypican-3-Specific Immunotherapy of Hepatocellular Carcinoma
Open the PDF for Identification of HLA-A2- or HLA-A24-Restricted CTL Epitopes Possibly Useful for Glypican-3-Specific Immunotherapy of Hepatocellular Carcinoma in another window
Journal Articles

A Potent Immunogenic General Cancer Vaccine That Targets Survivin, an Inhibitor of Apoptosis Proteins

Satomi Idenoue, Yoshihiko Hirohashi, Toshihiko Torigoe, Yuriko Sato, Yasuaki Tamura, Hiroyuki Hariu, Masaaki Yamamoto, Takehiro Kurotaki, Tetsuhiro Tsuruma, Hiroko Asanuma, Takayuki Kanaseki, Hideyuki Ikeda, Kiyoteru Kashiwagi, Minoru Okazaki, Kazuaki Sasaki, Takashi Sato, Tousei Ohmura, Fumitake Hata, Koji Yamaguchi, Koichi Hirata, Noriyuki Sato
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (4): 1474–1482.
https://doi.org/10.1158/1078-0432.CCR-03-0817
Published: 02 March 2005
View article titled, A Potent Immunogenic General Cancer Vaccine That Targets Survivin, an Inhibitor of Apoptosis Proteins
Open the PDF for A Potent Immunogenic General Cancer Vaccine That Targets Survivin, an Inhibitor of Apoptosis Proteins in another window
Journal Articles

Aberrant Expression and Potency as a Cancer Immunotherapy Target of Inhibitor of Apoptosis Protein Family, Livin/ML-IAP in Lung Cancer

Hiroyuki Hariu, Yoshihiko Hirohashi, Toshihiko Torigoe, Hiroko Asanuma, Midori Hariu, Yasuaki Tamura, Katsuyuki Aketa, Chika Nabeta, Katsuya Nakanishi, Kenjiro Kamiguchi, Yoshinori Mano, Hiroshi Kitamura, Junichi Kobayashi, Tomohide Tsukahara, Noriharu Shijubo, Noriyuki Sato
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (3): 1000–1009.
https://doi.org/10.1158/1078-0432.1000.11.3
Published: 11 February 2005
View article titled, Aberrant Expression and Potency as a Cancer Immunotherapy Target of Inhibitor of Apoptosis Protein Family, Livin/ML-IAP in Lung Cancer
Open the PDF for Aberrant Expression and Potency as a Cancer Immunotherapy Target of Inhibitor of Apoptosis Protein Family, Livin/ML-IAP in Lung Cancer in another window
Journal Articles

An HLA-A24-restricted Cytotoxic T Lymphocyte Epitope of a Tumor-associated Protein, Survivin

Yoshihiko Hirohashi, Toshihiko Torigoe, Akiko Maeda, Yuki Nabeta, Kenjiro Kamiguchi, Takashi Sato, Junichi Yoda, Hideyuki Ikeda, Kouichi Hirata, Noboru Yamanaka, Noriyuki Sato
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (6): 1731–1739.
Published: 01 June 2002
View article titled, An HLA-A24-restricted Cytotoxic T Lymphocyte Epitope of a Tumor-associated Protein, Survivin
Open the PDF for An HLA-A24-restricted Cytotoxic T Lymphocyte Epitope of a Tumor-associated Protein, Survivin in another window